A critical breakthrough in cancer investigation is emerging with the use of mini-antibodies to restore mutated p53. This crucial cancer inhibitor protein is frequently disabled in several types of tumors, resulting https://prbookmarkingwebsites.com/story29905651/nanobodies-revive-the-p53-protein-the-new-pathway-for-malignant-management